Pfizer’s Braftovi (encorafenib) regimen has been granted accelerated approval by the US Food and Drug Administration (FDA) to ...

As a result, there does seem to be more attention on the patient across med affairs, marketing and communications activity.

Is your medical education strategy reaching the right HCPs in the formats they prefer? Discover actionable insights to ...

Elevate your MedEd strategy with our 2025 toolkit! From AI-driven patient avatars to interactive augmented reality scenarios, ...

AI is shooting for the moon and the stars but the real benefits come from anchoring it to the human voice Research conducted ...

Merck & Co – known as MSD outside the US and Canada – will be gaining exclusive global rights to Hansoh Pharma’s preclinical ...

In theory, the principles of omnichannel – personalised content through the right channels to maximise customer experience – ...

If you are struggling to navigate the complexity of early commercialisation, rest assured, you are not alone. Clinical trial ...

For most of us working in healthcare communications, the best buzz is when the work has clearly reached those who are most in ...

Novo Nordisk has announced an investment of 8.5 billion Danish kroner, or approximately $1.2bn, to establish a new rare ...

Amgen’s Blincyto (blinatumomab) has been granted a licence extension by the Medicines and Healthcare products Regulatory ...

Approximately 121,000 people are diagnosed with primary advanced or recurrent endometrial cancer each year in Europe ...